trending Market Intelligence /marketintelligence/en/news-insights/trending/ZiY_dp0G3wQ1Lxqmba6khw2 content esgSubNav
In This List

Acer Therapeutics raises another $1.6M in stock offering

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Acer Therapeutics raises another $1.6M in stock offering

Acer Therapeutics Inc. said it raised additional gross proceeds of about $1.6 million after the underwriters of its common stock offering partially exercised their overallotment option.

Following the underwriters' purchase of an additional 130,000 shares at $12 apiece, the total number of shares sold increased to 1,046,667 shares and the total gross proceeds increased to $12.6 million.

The company plans to use the net proceeds to fund its research and development efforts, to seek regulatory approval for its product Edsivo, to invest in precommercial activities for Edsivo, and for general corporate purposes, including working capital and other general and administrative purposes.

William Blair & Co. LLC acted as sole book-running manager of the offering. H.C. Wainwright & Co. acted as lead manager of the offering.